Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
21
NCT00437502
A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer
Phase: Phase 1
Role: Collaborator
Start: Mar 31, 2007
Completion: Jan 31, 2010
NCT00674791
Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease
Start: Jun 30, 2007